Udayanath Aich, Ph.D.

Associate Director at Bristol Myers Squibb

Speaker

Dr. Uday Aich is a pharmaceutical leader with 18+ years of experience at the intersection of CMC strategy, technical operations, and enterprise program execution across small molecules, biologics, cell therapy, advanced therapeutics, LNP, peptides, and nucleotides — from early-phase through commercial manufacturing. Across GSK, Sanofi, Thermo Fisher, and BMS, he has led 15+ programs across 7+ global sites, building practical frameworks for process and analytical control strategy, enterprise risk management, and regulatory execution. His work spans CMC and analytical sciences, digital transformation through AI/ML and automation, and cross-functional portfolio leadership across oncology, rare disease, and cell therapy programs — with sustained budget and portfolio ownership at enterprise scale.